Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2007 Filed Feb 20, 2007 21:53 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Tax withholdingCommon shares without par value | 57,203 | $52.70 | $3,014,598.10 |
DisclosureSEC source: 0001104659-07-012310 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,156 Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 22:55 UTC |
Landgraf John CSenior Vice President
|
Tax withholdingCommon shares without par value | 7,101 | $52.70 | $374,222.70 |
DisclosureSEC source: 0001104659-07-012362 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,840 Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 22:55 UTC |
Chen Thomas FSenior Vice President
|
Tax withholdingCommon shares without par value | 7,101 | $52.70 | $374,222.70 |
DisclosureSEC source: 0001104659-07-012363 · a4.xml · nonDerivative · entry 1 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,420 Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 22:56 UTC |
LINDER GREG WVice President
|
Tax withholdingCommon shares without par value | 5,918 | $52.70 | $311,878.60 |
DisclosureSEC source: 0001104659-07-012365 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,057 Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 22:55 UTC |
Fussell Stephen RSenior Vice President
|
Tax withholdingCommon shares without par value | 5,918 | $52.70 | $311,878.60 |
DisclosureSEC source: 0001104659-07-012364 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,826 Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 23:24 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Tax withholdingCommon shares without par value | 5,169 | $52.70 | $272,406.30 |
DisclosureSEC source: 0001104659-07-012373 · a4.xml · nonDerivative · entry 4 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,463 Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 23:24 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
SaleCommon shares without par value | 1,500 | $52.81 | $79,215.00 |
DisclosureSEC source: 0001104659-07-012373 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,032 Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 22:58 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Tax withholdingCommon shares without par value | 6,554 | $52.70 | $345,395.80 |
DisclosureSEC source: 0001104659-07-012367 · a4.xml · nonDerivative · entry 4 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,232 Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 22:58 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
SaleCommon shares without par value | 1,800 | $52.81 | $95,059.80 |
DisclosureSEC source: 0001104659-07-012367 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,186 Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 23:25 UTC |
Hance Robert BSenior Vice President
|
Tax withholdingCommon shares without par value | 8,366 | $52.70 | $440,888.20 |
DisclosureSEC source: 0001104659-07-012374 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,615 Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 23:25 UTC |
Hance Robert BSenior Vice President
|
SaleCommon shares without par value | 2,200 | $52.80 | $116,160.00 |
DisclosureSEC source: 0001104659-07-012374 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,981 F1 · kind: This sale was made pursuant to a previously adopted plan complying with Rule 10b5-1(c). This plan was adopted on February 1, 2007. Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 23:50 UTC |
Tyree James LSenior Vice President
|
SaleCommon shares without par value | 1,500 | $52.83 | $79,245.00 |
DisclosureSEC source: 0001104659-07-012388 · a4.xml · nonDerivative · entry 2 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,605 Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 23:50 UTC |
Tyree James LSenior Vice President
|
Tax withholdingCommon shares without par value | 5,260 | $52.70 | $277,202.00 |
DisclosureSEC source: 0001104659-07-012388 · a4.xml · nonDerivative · entry 1 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,105 Read SEC document |
| February 15, 2007 Filed Feb 21, 2007 00:07 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Tax withholdingCommon shares without par value | 78,900 | $52.70 | $4,158,030.00 |
DisclosureSEC source: 0001104659-07-012392 · a4.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 843,073 Read SEC document |
| February 13, 2007 Filed Feb 15, 2007 20:22 UTC |
LINDER GREG WVice President
|
SaleCommon shares without par value | 1,265 | $52.63 | $66,575.69 |
DisclosureSEC source: 0001104659-07-011586 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,975 Read SEC document |
| February 13, 2007 Filed Feb 15, 2007 21:00 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 4,273 | $0.00 Strike: $47.33 | $0.00 |
DisclosureSEC source: 0001104659-07-011604 · a4.xml · derivative · entry 5 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 4,273 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 13, 2007 Filed Feb 15, 2007 21:00 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,119 | $0.00 Strike: $47.33 | $0.00 |
DisclosureSEC source: 0001104659-07-011604 · a4.xml · derivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,119 shares Expires 2007-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 13, 2007 Filed Feb 15, 2007 21:00 UTC |
Hance Robert BSenior Vice President
|
SaleCommon shares without par value | 5,392 | $52.67 | $283,980.46 |
DisclosureSEC source: 0001104659-07-011604 · a4.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,181 Read SEC document |
| February 13, 2007 Filed Feb 15, 2007 21:00 UTC |
Hance Robert BSenior Vice President
|
Exercise / conversionCommon shares without par value | 5,392 | $47.33 | $255,203.36 |
DisclosureSEC source: 0001104659-07-011604 · a4.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2007 Filed Feb 13, 2007 20:50 UTC |
Schumacher Laura JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 389 | $0.00 Strike: $39.01 | $0.00 |
DisclosureSEC source: 0001104659-07-010273 · a4.xml · derivative · entry 4 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 389 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 12, 2007 Filed Feb 13, 2007 20:50 UTC |
Schumacher Laura JSenior Vice President
|
SaleCommon shares without par value | 389 | $52.63 | $20,473.07 |
DisclosureSEC source: 0001104659-07-010273 · a4.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,704 Read SEC document |
| February 12, 2007 Filed Feb 13, 2007 20:50 UTC |
Schumacher Laura JSenior Vice President
|
Exercise / conversionCommon shares without par value | 389 | $39.01 | $15,175.36 |
DisclosureSEC source: 0001104659-07-010273 · a4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,093 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2007 Filed Feb 5, 2007 20:38 UTC |
ASHLEY RICHARD WExecutive Vice President
|
SaleCommon shares without par value | 2,800 | $52.72 | $147,604.80 |
DisclosureSEC source: 0001104659-07-007161 · a4.xml · nonDerivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,474 Read SEC document |
| February 02, 2007 Filed Feb 5, 2007 23:13 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,678 | $0.00 Strike: $43.00 | $0.00 |
DisclosureSEC source: 0001104659-07-007300 · a4.xml · derivative · entry 10 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,678 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 02, 2007 Filed Feb 5, 2007 23:13 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,170 | $0.00 Strike: $51.29 | $0.00 |
DisclosureSEC source: 0001104659-07-007300 · a4.xml · derivative · entry 9 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,170 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 02, 2007 Filed Feb 5, 2007 23:13 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
SaleCommon Shares without par value | 5,848 | $52.61 | $307,651.58 |
DisclosureSEC source: 0001104659-07-007300 · a4.xml · nonDerivative · entry 4 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,532 Read SEC document |
| February 02, 2007 Filed Feb 5, 2007 23:13 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Exercise / conversionCommon Shares without par value | 2,678 | $43.00 | $115,154.00 |
DisclosureSEC source: 0001104659-07-007300 · a4.xml · nonDerivative · entry 3 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,380 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2007 Filed Feb 5, 2007 23:13 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
Exercise / conversionCommon Shares without par value | 3,170 | $51.29 | $162,602.93 |
DisclosureSEC source: 0001104659-07-007300 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2007 Filed Feb 7, 2007 00:34 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
GrantOption (right to buy) · Derivative | 10,591 | $0.00 Strike: $52.87 | $0.00 |
DisclosureSEC source: 0001104659-07-007674 · a4.xml · derivative · entry 12 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,591 Underlying: common shares · 10,591 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 02, 2007 Filed Feb 7, 2007 00:34 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
GrantOption (right to buy) · Derivative | 44,824 | $0.00 Strike: $52.87 | $0.00 |
DisclosureSEC source: 0001104659-07-007674 · a4.xml · derivative · entry 11 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,824 Underlying: common shares · 44,824 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 02, 2007 Filed Feb 7, 2007 00:34 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
GrantOption (right to buy) · Derivative | 33,282 | $0.00 Strike: $52.87 | $0.00 |
DisclosureSEC source: 0001104659-07-007674 · a4.xml · derivative · entry 10 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,282 Underlying: common shares · 33,282 shares Expires 2014-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 02, 2007 Filed Feb 7, 2007 00:34 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 12,457 | $0.00 Strike: $41.64 | $0.00 |
DisclosureSEC source: 0001104659-07-007674 · a4.xml · derivative · entry 9 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,715 Underlying: common shares · 12,457 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 02, 2007 Filed Feb 7, 2007 00:34 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 53,171 | $0.00 Strike: $41.11 | $0.00 |
DisclosureSEC source: 0001104659-07-007674 · a4.xml · derivative · entry 8 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 53,171 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 02, 2007 Filed Feb 7, 2007 00:34 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 39,015 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-007674 · a4.xml · derivative · entry 7 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,507 Underlying: common shares · 39,015 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 02, 2007 Filed Feb 7, 2007 00:34 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Tax withholdingCommon shares without par value | 88,697 | $52.87 | $4,689,410.39 |
DisclosureSEC source: 0001104659-07-007674 · a4.xml · nonDerivative · entry 4 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,744 Read SEC document |
| February 02, 2007 Filed Feb 7, 2007 00:34 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionCommon shares without par value | 12,457 | $41.64 | $518,741.87 |
DisclosureSEC source: 0001104659-07-007674 · a4.xml · nonDerivative · entry 3 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,441 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2007 Filed Feb 7, 2007 00:34 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionCommon shares without par value | 53,171 | $41.11 | $2,185,694.98 |
DisclosureSEC source: 0001104659-07-007674 · a4.xml · nonDerivative · entry 2 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2007 Filed Feb 7, 2007 00:34 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionCommon shares without par value | 39,015 | $41.03 | $1,600,851.78 |
DisclosureSEC source: 0001104659-07-007674 · a4.xml · nonDerivative · entry 1 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,813 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2007 Filed Feb 5, 2007 20:38 UTC |
ASHLEY RICHARD WExecutive Vice President
|
Tax withholdingCommon shares without par value | 9,226 | $53.00 | $488,978.00 |
DisclosureSEC source: 0001104659-07-007161 · a4.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,274 Read SEC document |
| February 01, 2007 Filed Feb 5, 2007 23:10 UTC |
Fussell Stephen RSenior Vice President
|
GrantOption (right to buy) · Derivative | 21,975 | $0.00 Strike: $53.00 | $0.00 |
DisclosureSEC source: 0001104659-07-007299 · a4.xml · derivative · entry 8 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,975 Underlying: Common shares · 21,975 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 01, 2007 Filed Feb 5, 2007 23:10 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,304 | $0.00 Strike: $47.82 | $0.00 |
DisclosureSEC source: 0001104659-07-007299 · a4.xml · derivative · entry 7 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,304 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 01, 2007 Filed Feb 5, 2007 23:10 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 29,822 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-07-007299 · a4.xml · derivative · entry 6 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,813 Underlying: Common shares · 29,822 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 01, 2007 Filed Feb 5, 2007 23:10 UTC |
Fussell Stephen RSenior Vice President
|
SaleCommon shares without par value | 1,304 | $52.86 | $68,930.74 |
DisclosureSEC source: 0001104659-07-007299 · a4.xml · nonDerivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,744 Read SEC document |
| February 01, 2007 Filed Feb 5, 2007 23:10 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 1,304 | $47.82 | $62,357.28 |
DisclosureSEC source: 0001104659-07-007299 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2007 Filed Feb 5, 2007 23:10 UTC |
Fussell Stephen RSenior Vice President
|
Tax withholdingCommon shares without par value | 21,975 | $53.00 | $1,164,675.00 |
DisclosureSEC source: 0001104659-07-007299 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,744 Read SEC document |
| February 01, 2007 Filed Feb 5, 2007 23:10 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 29,822 | $33.23 | $991,026.81 |
DisclosureSEC source: 0001104659-07-007299 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2007 Filed Feb 1, 2007 23:42 UTC |
Hance Robert BSenior Vice President
|
SaleCommon shares without par value | 1,704 | $52.90 | $90,136.49 |
DisclosureSEC source: 0001104659-07-006562 · a4.xml · nonDerivative · entry 9 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,181 Read SEC document |
| January 31, 2007 Filed Feb 2, 2007 23:38 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 27,848 | $0.00 Strike: $53.19 | $0.00 |
DisclosureSEC source: 0001104659-07-006964 · a4.xml · derivative · entry 8 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,848 Underlying: common shares · 27,848 shares Expires 2009-02-11 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 2, 2007 23:38 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 31,920 | $0.00 Strike: $42.50 | $0.00 |
DisclosureSEC source: 0001104659-07-006964 · a4.xml · derivative · entry 7 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 31,920 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 31, 2007 Filed Feb 2, 2007 23:38 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 27,848 | $53.19 | $1,481,235.12 |
DisclosureSEC source: 0001104659-07-006964 · a4.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,966 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.